---
title: "Deferasirox - Beta Thalassemia"
sidebar: mydoc_sidebar
permalink: db01609-mesh-d017086-1.html
toc: false 
---


Path ID: `DB01609_MESH_D017086_1`
{% include image.html url="images/db01609-mesh-d017086-1.png" file="db01609-mesh-d017086-1.png" alt="db01609-mesh-d017086-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C415250 | Deferasirox | Drug |
| MESH:D007501 | Iron | ChemicalSubstance |
| HP:0012465 | Elevated hepatic iron concentration | PhenotypicFeature |
| MESH:D017086 | Beta Thalassemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Deferasirox | DECREASES ABUNDANCE OF | Iron |
| Iron | CORRELATED WITH | Elevated Hepatic Iron Concentration |
| Elevated Hepatic Iron Concentration | OCCURS IN | Beta Thalassemia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01609](https://go.drugbank.com/drugs/DB01609)
  - [https://en.wikipedia.org/wiki/Beta_thalassemia#Signs_and_symptoms](https://en.wikipedia.org/wiki/Beta_thalassemia#Signs_and_symptoms)
